Author:
Khara Jasmeet Singh,Priestman Miles,Uhía Iria,Hamilton Melissa Shea,Krishnan Nitya,Wang Ying,Yang Yi Yan,Langford Paul R.,Newton Sandra M.,Robertson Brian D.,Ee Pui Lai Rachel
Funder
Singapore Ministry of Health's National Medical Research Council
European Union's Seventh Framework Program
Imperial College London Biomedical Research Centre (BRC)
Institute of Bioengineering and Nanotechnology
Biomedical Research Council, Agency for Science, Technology and Research
Imperial College London Elsie Widdowson
National University of Singapore
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference28 articles.
1. WHO. Global Tuberculosis Report 2015 . Geneva: WHO, 2015. http://www.who.int/tb/publications/global_report/en/ .
2. WHO. The End TB Strategy . Geneva: WHO, 2015. http://www.who.int/tb/post2015_strategy/en/ .
3. Bedaquiline and delamanid in tuberculosis
4. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
5. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献